Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP.
Tobler LH, et al.
Transfusion. 2003 Oct;43(10):1452-9. doi: 10.1046/j.1537-2995.2003.00521.x.
Transfusion. 2003.
PMID: 14507279